Employees who enjoy their benefits are more inclined to stay with their company. A 2025 Marsh McLennan Agency report said 73% of employees would remain if plan options were better.

MedCity News

26.04.2025

CRISPR Biotech Caribou Trims Pipeline and Cuts 32% of Staff to Focus on Two Cancer Cell Therapies - MedCity News

Caribou Biosciences’ restructuring narrows the biotech’s focus to two off-the-shelf cell therapies for blood cancers, whose key data readouts have been pushed out to the second half of 2025. It’s the CRISPR-editing company’s second cash-saving restructuring in the past year.

MedCity News

26.04.2025

Community-Driven Digital Solutions Can Transform Addiction Treatment and Ease the Burden on the Healthcare System - MedCity News

Technology has the power to revolutionize treatment, make it more widely available, provide additional patient insight, and ultimately, alleviate the strain on our already stressed healthcare system.

MedCity News

26.04.2025

Orchestra BioMed’s Hypertension Device Wins FDA Breakthrough Designation - MedCity News

Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. Medtronic has a commercialization deal with the company for the device, which uses a pacing algorithm to actively lower blood pressure in people with pacemakers.

home›MedCity News

MedCity News

Health

5 Major Trends Emerging in Healthcare Benefits in 2025 - MedCity News

CRISPR Biotech Caribou Trims Pipeline and Cuts 32% of Staff to Focus on Two Cancer Cell Therapies - MedCity News

Community-Driven Digital Solutions Can Transform Addiction Treatment and Ease the Burden on the Healthcare System - MedCity News

Orchestra BioMed’s Hypertension Device Wins FDA Breakthrough Designation - MedCity News

home
›
MedCity News